CYP1A1 Ile462Val Polymorphism Contributes to Lung Cancer Susceptibility among Lung Squamous Carcinoma and Smokers: A Meta-Analysis

PLoS ONE

Volumn 7, Issue 8, 2012, Pages

  Ji, Ya Nan ^a   Wang, Qin ^b   Suo, Li jun ^c  

^a THE FIRST AFFILIATED HOSPITAL OF NANJING MEDICAL UNIVERSITY   (China)

^b No 81 Hospital of PLA   (China)

^c The Affiliated Linzi District People's Hospital of Binzhou Medical University   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOCHROME P450 1A1; ISOLEUCINE; VALINE;

AMINO ACID SUBSTITUTION; ARTICLE; ASIAN; CANCER RISK; CANCER SUSCEPTIBILITY; CASE CONTROL STUDY; CAUCASIAN; CIGARETTE SMOKING; CORRELATION ANALYSIS; GENETIC POLYMORPHISM; GENOTYPE; HISTOPATHOLOGY; HUMAN; LUNG CARCINOMA; LUNG SMALL CELL CANCER; POPULATION GENETICS; SQUAMOUS CELL CARCINOMA; SYSTEMATIC REVIEW;

CARCINOMA, SQUAMOUS CELL; CASE-CONTROL STUDIES; CYTOCHROME P-450 CYP1A1; EXONS; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; ISOLEUCINE; LUNG NEOPLASMS; MODELS, GENETIC; ODDS RATIO; POLYMORPHISM, GENETIC; SMOKING; VALINE;

EID: 84865457724     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0043397     Document Type: Article

References (62)

1. Alberg AJ, Samet JM, (2003) Epidemiology of lung cancer. Chest 123: 21-49.
2. Molina JR, Yang P, Cassivi SD, Schild SE, Adjei AA, (2008) Non-small cell lung cancer: epidemiology, risk factors, treatment, and survivorship. Mayo Clin Proc 83: 584-594.
3. Alberg AJ, Brock MV, Samet JM, (2005) Epidemiology of lung cancer: looking to the future. J Clin Oncol 23: 3175-85.
4. Rodriguez V, Tardon A, Kogevinas M, Prieto CS, Cueto A, et al. (2000) Lung cancer risk in iron and steel foundry workers: a nested case control study in Asturias, Spain. Am J Ind Med 38: 644-50.
5. Tardon A, Lee WJ, Delgado-Rodriguez M, Dosemeci M, Albanes D, et al. (2005) Leisure-time physical activity and lung cancer: a meta-analysis. Cancer Causes Control 16: 389-97.
6. Guengerich FP, Shimada T, (1998) Activation of procarcinogens by human cytochrome P450 enzymes. Mutat Res 400: 201-213.
7. Butler JP, Post GB, Lioy PJ, Waldman JM, Greenberg A, (1993) Assessment of carcinogenic risk from personal exposure to benzo[a]pyrene in the total human environmental exposure study(THEES). J Air Waste Manag Assoc 43: 970-977.
8. Kawajiri K, Eguchi H, Nakachi K, (1996) Association of CYP1A1 germ line polymorphisms with mutations of the p53 gene in lung cancer. Cancer Res 56: 72-76.
9. Kawajiri K, Nakachi K, Imai K, Yoshii A, Shinoda N, et al. (1990) Identification of genetically high risk individuals to lung cancer by DNA polymorphisms of the cytochrome P450IA1 gene. FEBS 1: 131-133.
10. Houlston RS, (2000) CYP1A1 polymorphisms and lung cancer risk: a meta-analysis. Pharmacogenetics 10: 105-14.
11. Le Marchand L, Guo C, Benhamou S, Bouchardy C, Cascorbi I, et al. (2003) Pooled analysis of the CYP1A1 exon 7 polymorphism and lung cancer (United States). Cancer Causes Control 14: 339-46.
12. Shi X, Zhou S, Wang Z, Zhou Z, Wang Z, (2008) CYP1A1 and GSTM1 polymorphisms and lung cancer risk in Chinese populations: a meta-analysis. Lung Cancer 59: 155-63.
13. Cochran WG, (1954) The combination of estimates from different experiments. Biometrics 10: 101-29.
14. Mantel N, Haenszel W, (1959) Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst 22: 719-48.
15. DerSimonian R, Laird N, (1986) Meta-analysis in clinical trials. Control Clin Trials 7: 177-88.
16. Tobias A, (1999) Assessing the influence of a single study in the meta-analysis estimate. Stata Tech Bull 8: 15-7.
17. Egger M, Davey Smith G, Schneider M, Minder C, (1997) Bias in metaanalysis detected by a simple, graphical test. BMJ 315: 629-34.
18. Nakachi K, Imai K, Hayashi S, Kawajiri K, (1993) Polymorphisms of the CYP1A1 and glutathione S-transferase genes associated with susceptibility to lung cancer in relation to cigarette dose in a Japanese population. Cancer Res 53: 2994-9.
19. Alexandrie AK, Sundberg MI, Seidegård J, Tornling G, Rannug A, (1994) Genetic susceptibility to lung cancer with special emphasis on CYP1A1 and GSTM1: a study on host factors in relation to age at onset, gender and histological cancer types. Carcinogenesis 15: 1785-90.
20. Kihara M, Kihara M, Noda K, (1995) Risk of smoking for squamous and small cell carcinomas of the lung modulated by combinations of CYP1A1 and GSTM1 gene polymorphisms in a Japanese population. Carcinogenesis 16: 2331-6.
21. Cantlay AM, Lamb D, Gillooly M, Norrman J, Morrison D, et al. (1995) Association between the CYP1A1 gene polymorphism and susceptibility to emphysema and lung cancer. Clin Mol Pathol 48: 210-214.
22. Ishibe N, Wiencke JK, Zuo ZF, McMillan A, Spitz M, et al. (1997) Susceptibility to lung cancer in light smokers associated with CYP1A1 polymorphisms in Mexican and African-Americans. Cancer Epidemiol Biomarkers Prev 6: 1075-80.
23. Hong YS, Chang JH, Kwon OJ, Ham YA, Choi JH, (1998) Polymorphism of the CYP1A1 and glutathione-S-transferase gene in Korean lung cancer patients. Exp Mol Med 30: 192-8.
24. Sugimura H, Wakai K, Genka K, Nagura K, Igarashi H, et al. (1998) Association of Ile462Val (Exon 7) polymorphism of cytochrome P450 IA1 with lung cancer in the Asian population: further evidence from a case-control study in Okinawa. Cancer Epidemiol Biomarkers Prev 7: 413-7.
25. Taioli E, Ford J, Trachman J, Li Y, Demopoulos R, et al. (1998) Lung cancer risk and CYP1A1 genotype in African Americans. Carcinogenesis 19: 813-7.
26. Le Marchand L, Sivaraman L, Pierce L, Seifried A, Lum A, et al. (1998) Associations of CYP1A1, GSTM1, and CYP2E1 polymorphisms with lung cancer suggest cell type specificities to tobacco carcinogens. Cancer Res 58: 4858-63.
27. Xue KX, Xu L, Chen S, (1999) Polymorphisms of the CYP1A1 and GSTM1 genes and lung cancer risk in chinese population [in Chinese].Carcinogenesis Teratogenesis and Mutagenesis. 11: 228-230.
28. Hu YL, Zhang Qi, (1999) Genetic Polymorphisms of CYP1A1 and Susceptibility of Lung Cancer [in Chinese]. Chin J Med Genet 16: 26-28.
29. London SJ, Yuan JM, Coetzee GA, Gao YT, Ross RK, et al. (2000) CYP1A1 I462V genetic polymorphism and lung cancer risk in a cohort of men in Shanghai, China. Cancer Epidemiol Biomarkers Prev 9: 987-91.
30. Xue KX, Xu L, Chen S, Ma GJ, Wu JZ, (2001) Polymorphisms of the CYP1A1 and GSTM1 genes and their combined effects on individual susceptibility to lung cancer in a chinese pupulation[in Chinese]. Chin J Med Genet 18: 125-127.
31. Ratnasinghe D, Tangrea JA, Stewart C, Bhat NK, Virtamo J, et al. (2001) Influence of antioxidants and the CYP1A1 isoleucine to valine polymorphism on the smoking-lung cancer association. Anticancer Res 21: 1295-9.
32. Quiñones L, Lucas D, Godoy J, Cáceres D, Berthou F, et al. (2001) CYP1A1, CYP2E1 and GSTM1 genetic polymorphisms. The effect of single and combined genotypes on lung cancer susceptibility in Chilean people. Cancer Lett 174: 35-44.
33. Song N, Tan W, Xing D, Lin D, (2001) CYP 1A1 polymorphism and risk of lung cancer in relation to tobacco smoking: a case-control study in China. Carcinogenesis 22: 11-6.
34. Chen S, Xue K, Xu L, Ma G Wu J (2001) Polymorphisms of the CYP1A1 and GSTM1 genes in relation to individual susceptibility to lung carcinoma in Chinese population. Mutat. Res 458, 41-47.
35. Zhou X, Shi Y, Zhou Y, (2002) The Relationship betweenCYP1A1Genetic Polymorphism and Susceptibility to Lung Cancer [in Chinese]. Chin J Environ Occup Med 19: 355-367.
36. Taioli E, Gaspari L, Benhamou S, Boffetta P, Brockmoller J, et al. (2003) Polymorphisms in CYP1A1, GSTM1, GSTT1 and lung cancer below the age of 45 years. Int J Epidemiol 32: 60-3.
37. Dong CT, Yang Q, Wang MZ, Dong QN, (2004) A study on the relationship between polymorphism of CYP1A1, Lack of GSTM1 and susceptibility to lung cancer [in Chinese]. J Environ Occup Med 21: 440-442.
38. Sobti RC, Sharma S, Joshi A, Jindal SK, Janmeja A, (2004) Genetic polymorphism of the CYP1A1, CYP2E1, GSTM1 and GSTT1 genes and lung cancer susceptibility in a north indian population. Mol Cell Biochem 266: 1-9.
39. Yang XR, Wacholder S, Xu Z, Dean M, Clark V, et al. (2004) CYP1A1 and GSTM1 polymorphisms in relation to lung cancer risk in Chinese women. Cancer Lett 214: 197-204.
40. Wrensch MR, Miike R, Sison JD, Kelsey KT, Liu M, et al. (2005) CYP1A1 variants and smoking-related lung cancer in San Francisco Bay area Latinos and African Americans. Int J Cancer 113: 141-7.
41. Ng DP, Tan KW, Zhao B, Seow A, (2005) CYP1A1 polymorphisms and risk of lung cancer in non-smoking Chinese women: influence of environmental tobacco smoke exposure and GSTM1/T1 genetic variation. Cancer Causes Control 16: 399-405.
42. Larsen JE, Colosimo ML, Yang IA, Bowman R, Zimmerman PV, et al. (2005) Risk of non-small cell lung cancer and the cytochrome P4501A1 Ile462Val polymorphism. Cancer Causes Control 16: 579-85.
43. Raimondi S, Boffetta P, Anttila S, Bröckmoller J, Butkiewicz D, et al. (2005) Metabolic gene polymorphisms and lung cancer risk in non-smokers. An update of the GSEC study. Mutat Res 592: 45-57.
44. Wenzlaff AS, Cote ML, Bock CH, Land SJ, Santer SK, et al. (2005) CYP1A1 and CYP1B1 polymorphisms and risk of lung cancer among never smokers: a population-based study. Carcinogenesis 26: 2207-12.
45. Li DR, Zhou QH, Guo ZL, (2006) Relationship between genetic polymorphism of CYP1A1 and lung cancer genetic susceptibility [in Chinese]. Chin J Cancer Prev Treat 13: 1765-1768.
46. Pisani P, Srivatanakul P, Randerson-Moor J, Vipasrinimit S, Lalitwongsa S, et al. (2006) GSTM1 and CYP1A1 polymorphisms, tobacco, air pollution, and lung cancer: a study in rural Thailand. Cancer Epidemiol Biomarkers Prev 15: 667-74.
47. Yang M, Choi Y, Hwangbo B, Lee JS, (2007) Combined effects of genetic polymorphisms in six selected genes on lung cancer susceptibility. Lung Cancer 57: 135-42.
48. Cote ML, Wenzlaff AS, Bock CH, Land SJ, Santer SK, et al. (2007) Combinations of cytochrome P-450 genotypes and risk of early-onset lung cancer in Caucasians and African Americans: a population-based study. Lung Cancer 55: 255-62.
49. Yoon KA, Kim JH, Gil HJ, Hwang H, Hwangbo B, et al. (2008) CYP1B1, CYP1A1, MPO, and GSTP1 polymorphisms and lung cancer risk in never-smoking Korean women. Lung Cancer 60: 40-6.
50. Gallegos-Arreola MP, Figuera-Villanueva LE, Troyo-Sanroman R, Morgán-Villela G, Puebla-Pérez AM, et al. (2008) CYP1A1 *2B and *4 polymorphisms are associated with lung cancer susceptibility in Mexican patients. Int. J. Biol. Markers 23: 24-30.
51. Shah PP, Singh AP, Singh M, Mathur N, Pant MC, et al. (2008) Interaction of cytochrome P4501A1 genotypes with other risk factors and susceptibility to lung cancer. Mutat Res 639: 1-10.
52. Kumar M, Agarwal SK, Goel SK, (2009) Lung cancer risk in north Indian population: role of genetic polymorphisms and smoking. Mol Cell Biochem 322: 73-9.
53. Cote ML, Yoo W, Wenzlaff AS, Prysak GM, Santer SK, et al. (2009) Tobacco and estrogen metabolic polymorphisms and risk of non-small cell lung cancer in women. Carcinogenesis 30: 626-635.
54. Klinchid J, Chewaskulyoung B, Saeteng S, Lertprasertsuke N, Kasinrerk W, et al. (2009) Effect of combined genetic polymorphisms on lung cancer risk in northern Thai women. Cancer Genet Cytogenet 195: 143-149.
55. Timofeeva MN, Kropp S, Sauter W, Beckmann L, Rosenberger A, et al. (2009) CYP450 polymorphisms as risk factors for early-onset lung cancer: gender-specific differences. Carcinogenesis 301161-1169.
56. Wright CM, Larsen JE, Colosimo ML, Barr JJ, Chen L, et al. (2010) Genetic association study of CYP1A1 polymorphisms identifies risk haplotypes in nonsmall cell lung cancer. Eur Respir J 35: 152-159.
57. Mota P, Moura DS, Vale MG, Coimbra H, Carvalho L, et al. (2010) CYP1A1 m1 and m2 polymorphisms: genetic susceptibility to lung cancer. Rev Port Pneumol 16: 89-98.
58. Bai TY, Chang FH, Wang MJ, (2011) Relationship between GSTT1 and CYP1A1 genetic polymorphisms and lung cancer susceptibility. Chin J Public Health 27: 723-725.
59. Wang ZZ, Wang CB, Ma YG, (2011) Association of I462V polymorphism of gene with non-small cell lung cancer. Progressof Anatomical Sciences 17: 361-363.
60. Hirschhorn JN, Lohmueller K, Byrne E, (2002) A comprehensive reviewof genetic association studies. Genet Med 4: 45-61.
61. Sato S, Nakamura Y, Tsuchiya E, (1994) Difference of allelotype between squamous cell carcinoma and adenocarcinoma of the lung. Cancer Res 54: 5652-5.
62. Wydner EL, Hoffman D, (1994) Smoking and lung cancer: scientific challenges and opportunities. Cancer Res 54: 5284-95.